Frédérique Nowak

Biomarkers (BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts).

Fabrice Barlési, Hélène Blons, Michèle Beau‐Faller et al. · Journal of Clinical Oncology · 2013 · 112 citations

Medicine, Oncology, Pathology +17

Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.

Denis Moro‐Sibilot, Laura Faivre, Gérard Zalcman et al. · Journal of Clinical Oncology · 2015 · 47 citations

Medicine, Oncology, Pharmacology +17

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer

Elisabeth Dequeker, Cleo Keppens, C. Egelé et al. · Journal of Molecular Diagnostics · 2016 · 41 citations

Medicine, Molecular Medicine, Oncology +12

IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: Application to the analysis of seven human prostate cell lines

Joan Aurich‐Costa, Anne Vannier, Eric Grégoire et al. · Genes Chromosomes and Cancer · 2001 · 36 citations

Medicine, Molecular Biology, Oncology +14

Biomarker Discovery, Development, and Implementation in France: A Report from the French National Cancer Institute and Cooperative Groups

Fabrice André, Frédérique Nowak, Mónica Arnedos et al. · Clinical Cancer Research · 2012 · 34 citations · Full text

Medicine, Molecular Biology, Oncology +14